Astellas Pharma Inc. v. Sandoz Inc. Myrbetriq® (Mirabegron)

Case Name: Astellas Pharma Inc. v. Sandoz Inc., Civ. No. 20-1589, 2023 WL 3934386 (D. Del. June 9, 2023) (Bataillon, J.) Drug Product and Patent(s)-in-Suit: Myrbetriq® (mirabegron); U.S. Patent No. 10,842,780 (“the ’780 patent”)….
By: Robins Kaplan LLP